Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.
Seymour, Leonard W; Ferry, David R; Kerr, David J; Rea, Daniel; Whitlock, Maggie; Poyner, Richard; Boivin, Christopher; Hesslewood, Stuart; Twelves, Christopher; Blackie, Robert; Schatzlein, Andreas; Jodrell, Duncan; Bissett, Donald; Calvert, Hilary; Lind, Mike; Robbins, Adele; Burtles, Sally; Duncan, Ruth; Cassidy, James.
Int J Oncol
; 34(6): 1629-36, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19424581
Pharmacokinetic-pharmacodynamic modelling of acute N-terminal pro B-type natriuretic peptide after doxorubicin infusion in breast cancer.
Metabolism and pharmacokinetics of allitinib in cancer patients: the roles of cytochrome P450s and epoxide hydrolase in its biotransformation.
Refilling drug delivery depots through the blood.
Review of bioanalytical assays for the quantitation of various HDAC inhibitors such as vorinostat, belinostat, panobinostat, romidepsin and chidamine.
Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients.
Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models.
A high-performance liquid chromatography-tandem mass spectrometry method for simultaneous determination of imigliptin, its five metabolites and alogliptin in human plasma and urine and its application to a multiple-dose pharmacokinetic study.
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients.
Effect of Chemical Binding of Doxorubicin Hydrochloride to Gold Nanoparticles, Versus Electrostatic Adsorption, on the In Vitro Drug Release and Cytotoxicity to Breast Cancer Cells.
Riboflavin-targeted polymer conjugates for breast tumor delivery.